Industry defenders will argue, “but Revlimid has competition.” Here’s @davidp4ad.bsky.social explaining why that’s not actually true.

One of several references on this point:
www.healthaffairs.org/doi/abs/10.1...

RFK says, “we have measles outbreaks every year.” Not totally true. Back when vaccinations rates were higher, with fewer pockets of unvaccinated kids, we’d have around 60 mostly imported measles cases/yr. The cases were isolated and didn’t grow into outbreaks
www.washingtonpost.com/health/2025/...

Buyer Beware: The American Action Forum is a subsidiary of the American Action Network which has received-are you sitting down-more than $27 million from pharma since 2010. When you see anything from @AAF or @AAN, remember it's all drug company propaganda bought and paid for.

How do you spell relief? IRA—the Inflation Reduction Act’s $2,000 out-of-pocket cap kicks in today. Millions of patients on Medicare Part D will see big savings—especially cancer patients. www.nbcnews.com/health/healt...

As always, like clockwork, drug companies raise prices on hundreds of drugs to start the new year. No justification. Just because they can. We let them. www.reuters.com/business/hea...

Here's another drug company investing in small molecules. Must believe they can make money despite claims and complaints from pharma that 9 years before possible Medicare negotiation is not enough. endpts.com/novo-nordisk...

This is why we need PBM reforms including those in the newly announced Continuing Resolution. PBMs do not work to give patients the best drugs at the lowest prices--too often they push the drugs that give them the greatest profits at the expense of patients. chaindrugreview.com/medicare-pla...

Drug companies say reforms in the new drug price law harm investment & innovation. But a new survey contradicts those claims.
"3/4 of executives surveyed say they’re optimistic, driven by strong growth expectations, scientific innovation and precision medicine." www.mmm-online.com/news/pharma-...

This from Prof. Robin Feldman explains why we need to reform our patent laws and why S.150 addressing the abuse of patent thickets is such an important part of the CR now moving in Congress. yalelawandpolicy.org/patent-term-...

PBMs and drug companies BOTH prosper unethically in our current system; they both need reform because they don't put patients/consumers first. Instead they put profits first at the expense of patients' health and financial well-being.
www.nytimes.com/2024/12/17/b...

Big Pharma’s patent games extend their monopolies and block competition to keep drug prices high — costing patients, taxpayers and the U.S. health care system billions annually.
It’s time to pass Cornyn-Blumenthal to stop Big Pharma’s patent blockades and lower drug prices.
H/T CSRxP

Strong opposition by advocates to this bad bill made its passage out of committee a squeaker: 11-to-10. There was strong bipartisan opposition for good reason. We continue to fight it and oppose allowing it to come to Senate floor for a vote. pirg.org/updates/disa...

PhRMA is peddling crap. Study projecting higher costs for 8% of people on Medicare is bogus--absurdly assumes people on Medicare take 1 drug at a time when they fill about 5 Rxs/month. Doesn't reflect other IRA savings.
Facts: IRA delivering lower prices & oop, lower ave premiums, plenty of choice.

Congress can take a key step to lower drug prices by passing the Affordable Prescriptions for Patients Act. The Senate passed it unanimously. Now the House must act. It'll help patients, employers & employees. Thanks JamesGelfand for co-authoring.
dcjournal.com/patent-thick...